1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Zielinski, C.C, Lang, I, Inbar, M, Kahan, Z, Greil, R, Beslija, S, Stemmer, S.M, Zvirbule, Z, Steger, G.G, Melichar, B, Pienkowski, T, Sirbu, D, Petruzelka, L, Eniu, A, Nisenbaum, B, Dank, M, Anghel, R, Messinger, D, Brodowicz, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Clinical outcomes following Recurrence Score-based therapy in N+ ER+ breast cancer: a cohort study
Stemmer, S, Steiner, M, Rizel, S, Geffen, D, Nisenbaum, B, Peretz, T, Isaacs, K, Rosengarten, O, Fried, G, Svedman, C, Ben-Baruch, N
Published in Breast (Edinburgh) (01.03.2017)
Published in Breast (Edinburgh) (01.03.2017)
Get full text
Journal Article
1963 First prospective outcome data in 930 patients with more than 5 year median follow up in whom treatment decisions in clinical practice have been made incorporating the 21-Gene Recurrence Score
Stemmer, S, Steiner, M, Rizel, S, Ben-Baruch, N, Soussan-Gutman, L, Rosengarten, O, Geffen, D, Nisenbaum, B, Ryvo, L, Uziely, B, Fried, G, Svedman, C, Rothney, M, Klang, S, Kaufman, B, Isaacs, K, Evron, E, Zidan, J, Shak, S, Liebermann, N
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Recurrence score results in elderly patients with estrogen receptor positive early breast cancer
Steiner, M, Ciuraru, N.B, Nisenbaum, B, Ryvo, L, Uziely, B, Geffen, D, Drumea, K, Leviov, M, Rizel, S, Stemmer, S
Published in Journal of geriatric oncology (01.10.2013)
Published in Journal of geriatric oncology (01.10.2013)
Get full text
Journal Article
Abstract P1-07-14: Real-life analysis evaluating >1000 N0/N1mi estrogen receptor (ER)+ breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score (RS) result: Clinical outcomes with median follow up of > 9 years
Stemmer, SM, Rizel, S, Steiner, M, Geffen, DB, Soussan-Gutman, L, Bareket-Samish, A, McCullough, D, Svedman, C, Nisenbaum, B, Ryvo, L, Peretz, T, Fried, G, Rosengarten, O, Liebermann, N, Ben Baruch, N
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization
Stemmer, S.M., Leviov, M., Tokar, M., Ben-Baruch, N., Uziely, B., Fried, G., Rosengarten, O., Itay, A., Nisenbaum, B., Shak, S.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
P249 - Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization
Stemmer, S.M., Leviov, M., Tokar, M., Ben-Baruch, N., Uziely, B., Fried, G., Rosengarten, O., Itay, A., Nisenbaum, B., Shak, S.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) result
Stemmer, S.M., Steiner, M., Rizel, S., Geffen, D., Nisenbaum, B., Peretz, T., Soussan-Gutman, L., Bareket-Samish, A., Isaacs, K., Rosengarten, O., Fried, G., Svedman, C., Shak, S., Liebermann, N., Ben-Baruch, N.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
P251 - Clinical outcomes following Recurrence Score-based therapy in N+ ER+ breast cancer: a cohort study
Stemmer, S., Steiner, M., Rizel, S., Geffen, D., Nisenbaum, B., Peretz, T., Isaacs, K., Rosengarten, O., Fried, G., Svedman, C., Ben-Baruch, N.
Published in Breast (Edinburgh) (01.03.2017)
Published in Breast (Edinburgh) (01.03.2017)
Get full text
Journal Article
Abstract P5-20-06: RAD001 (Everolimus) in combination with Letrozole in the treatment of postmenopausal women with estrogen receptor positive Metastatic Breast cancer after failure of hormonal therapy – a phase II study
Safra, T, Kaufman, B, Ben, Baruch N, Kadouri-Sonenfeld, L, Nisenbaum, B, Greenberg, J, Ryvo, L, Yerushalmi, R, Evron, E
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract P5-08-02: Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98
Stemmer, SM, Steiner, M, Rizel, S, Soussan-Gutman, L, Geffen, DB, Nisenbaum, B, Ben-Baruch, N, Isaacs, K, Fried, G, Rosengarten, O, Uziely, B, Svedman, C, Rothney, M, Klang, SH, Ryvo, L, Kaufman, B, Evron, E, Zidan, J, Shak, S, Liebermann, N
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Local excision after neoadjuvant chemoradiation for rectal cancer: Is it an acceptable treatment option?
Brenner, B., Brenner, R., Puirm, O., Peled, N., Idelevich, E., Nisenbaum, B., Fenig, E., Sulkes, A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
First Efficacy Results From the Turandot Phase III Trial Comparing Two Bevacizumab (BEV)-Containing Regimens as First-Line Therapy for HER2-Negative Metastatic Breast Cancer (MBC)
Zielinski, C., Lang, I., Inbar, M., Kahan, Z., Greil, R., Beslija, S., Stemmer, S.M., Kaufman, B., Zvirbule, Z., Steger, G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenbaum, B., Dank, M., Anghel, R., Messinger, D., Brodowicz, T.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Prognostic factors for tumor histological response to preoperative chemoradiation in rectal cancer
Kundel, Y., Brenner, R., Abramovich, A., Purim, O., Peled, N., Idelevich, E., Nisenbaum, B., Fenig, E., Sulkes, A., Brenner, B.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Intracavity gamma therapy of microcarcinoma of the cervix uteri
Vishnevskaia, E E, Murav'ev, G N, Nisenbaum, B L
Published in Meditsinskaia radiologiia (01.09.1988)
Get more information
Published in Meditsinskaia radiologiia (01.09.1988)
Journal Article
DEVICE FOR DETERMINING MAXIMUM NUMBER CODE
MAZNICHENKO ALEKSANDR YA,SU, IVANOV OLEG V,SU, PALKIN ANATOLIJ V,SU, NISENBAUM EVGENIJ B,SU
Year of Publication 15.05.1981
Get full text
Year of Publication 15.05.1981
Patent